In the majority of HLs, gains of MDM2 or loss-of-function mutations of TP53 have been reported, which suggests that the P53 signaling pathway is probably not functional in cases with these genetic aberrations (Küppers, 2009) (Figure 1C). The gene discussed is TP53; the disease is Hydrolethalus.